Biopsy | Medical XPRT
Articles & Whitepapers
-
Study of the pathogenic mechanisms of autoimmune myasthenia gravis - Case Study
Contexte Myasthenia gravis (MG) is an autoimmune disease caused by the presence of antibodies directed against components of the muscle membrane located at the neuromuscular junction. In the majority of cases, these are autoantibodies directed against the acetylcholine receptor (AChR). The origin of the autoimmune response is not known, but thymic abnormalities and defective regulation of the ...
-
Case Study B - Liquid Biopsy
X-ZELL is collaborating with Singapore General Hospital (SGH) and the National University Hospital Singapore (NUH) to explore how X-ZELL single-cell diagnostics may aid in the early detection of ...
News
-
Carcinotech and CELLINK Enter a Partnership to Develop and Commercialize Protocols for Cancer Models to Provide Improved Speed and Accuracy in the Drug Development Processes
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug ...
Equipment & Solutions
-
Showcase
Flexible HD Video Gastroscope for Large Animals
The FVG Video Gastroscopes also feature a waterproof insertion probe with 4-way tip articulation, an instrument channel for flexible forceps, additional channels for air/water, and suction (additional unit required), a wide angle 140 degree field of view, a focal range of 5mm – 100mm from the tip, and a 200 watt Halogen light source incorporated into the design. For customers looking to ...
Upcoming Events
-
Showcase
The 7th Global MASLD Congress
MASH/MASLD incidence rates are continuing to rise globally year after year as the disease continues to be a global health concern. Although no pharmaceutical drugs have yet received regulatory approval, there are a number of therapeutics in late phase clinical trials; case studies of which will be discussed at the congress as well as pre-clinical developments. Potential alternatives for MASH ...